Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened

Predictive Oncology Inc. (NASDAQ:POAI)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $5.45 and traded as low as $3.4309. Predictive Oncology shares last traded at $3.52, with a volume of 73,527 shares.

Predictive Oncology Trading Down 2.5%

The stock has a 50-day simple moving average of $2.47 and a 200 day simple moving average of $5.45. The stock has a market capitalization of $11.95 million, a price-to-earnings ratio of -0.26 and a beta of 1.35.

About Predictive Oncology

Predictive Oncology, Inc is a biotechnology company that leverages artificial intelligence and digital biology to support drug discovery and development in oncology. Its core business revolves around the application of machine learning algorithms to high-content cellular imaging, multi-omic profiling, and clinical response data. By integrating these diverse data streams, the company aims to generate predictive models that forecast the efficacy and toxicity of candidate therapeutics, thereby accelerating preclinical decision-making and reducing development timelines.

The company’s primary offerings include its Phenomics platform, which combines automated microscopy with advanced image analysis to capture subtle phenotypic changes in cancer cells.